A phase 3, single-arm, open-label study to evaluate the safety, tolerability, and immunogenicity of a 15-valent pneumococcal conjugate vaccine, V114, in a 3+1 regimen in healthy infants in South Korea (PNEU-PED-KOR)

• Main Authors: Alvino Maestri (Author), Su Eun Park (Author), Fiona Fernandes (Author), Zhongyi "Lucy" Li (Author), Yae-Jean Kim (Author), Yun-Kyung Kim (Author), Jin Lee (Author), Ji Young Park (Author), Dong Hyun Kim (Author), GyongSeon Yang (Author), Hyunjung Lim (Author), Jin Oh Kim (Author), Robert Lupinacci (Author), Tina M. Sterling (Author), Marissa Wilck (Author), Alejandra Esteves-Jaramillo (Author), Natalie Banniettis (Author)
• Format: Book
• Published: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

ABSTRACTThere is an ongoing burden of pneumococcal disease in children despite the use of pneumococcal conjugate vaccines (PCVs). This phase 3, open-label, single-arm, multisite, descriptive study was designed to evaluate the safety and immunogenicity of a 3 + 1 regimen of V114 (VAXNEUVANCE™), a 15-...